Virbac: Positive financial results at the end of September

Virbac announced a 12.6% growth in its turnover at the end of September 2024, reaching 1,042.1 million euros. This increase includes an organic growth of 8.6% at constant exchange rates and scope. The acquisitions of Globion in India and Sasaeah in Japan contributed to this performance, adding 5.4 percentage points.

In the third quarter, Virbac's sales increased by 7.7% at real rates, totaling €339.2 million. Growth is mainly due to acquisitions, while organic growth was 3.4% over the period.

The outlook remains positive for 2024, with growth forecasts of between 7% and 9% at constant rates. Virbac also expects its profitability to continue to increase. The integration of the new companies should make a significant contribution.